- Archives
-
-
-
-
-
-
-
-
-
-
A market overview of this critical area of drug manufacturing
Gil Y. Roth
What to look for in a contract lab
Dr. Anthony Qu, Ph.D., and Amy Maglayo, B.Sc.
Contractors reach earlier into the drug development process
Steven Heffner
How Emerging Pharma can build value
Enrico Polastro
How to handle bio-outsourcing
George F. Klein
Management practices for unforeseen API challenges
Cliff R. King, Ph.D.
Understanding virtual relationships
J. Fred Pritchard, Ph.D., and Edward Leung, Ph.D.
Jockeying for position in the race to become \\\"partner of choice\\\"
Jon Hess and Elio Evangelista
Examining the packaging sector
Gil Y. Roth
A comparative analysis
By Dr. Faiz Kermani and Pietro Bonacossa
Our annual look at the 20 biggest players in the pharmaceutical marketplace
Our annual look at the top 10 standalone biopharmaceutical companies
A survey of best-in-class practices for outsourcing management
Jennifer Parkhurst
Examining the contract biomanufacturing sector
Gil Y. Roth
IT connectivity in pharma and biopharma manufacturing
Frederick Doubleday
Read the results from Contract Pharma's annual salary survey
Strengths, challenges and outlook for the CRO industry
Sarah W. Madley
A Quality Assurance perspective
Edith Lewis-Rogers
How have they changed clinical study report development?
Monique Garrett
Who's responsible when something goes wrong in a biomanufacturing partnership?
Sandra Fox, MBA, Gary Ogden, MBA, Helen Wang Ph.D., Lynne Sopchak, Ph.D, and Shauna Farr-Jones, Ph.D.
Assessing outsource/in-house options for analytical labs
Thomas C. Kupiec, Ph.D.
How mid-tier pharma and biopharma can improve efficiency,reduce cost, and achieve compliance
Cary Smithson
Multiple factors lead to business growth
Aaron K. Finkelstein
Closing the gap between innovation and commercial manufacturing
Cliff R. King, Ph. D.
Information for contract packagers
Peter C. Mayberry
Continuing our series on 21CFR11 compliance
Kevin Lloyd
|
